Report Overview
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
The global Hepatitis B Vaccine (Recombinant) market size was estimated at USD 1021.80 million in 2023 and is projected to reach USD 1344.91 million by 2032, exhibiting a CAGR of 3.10% during the forecast period.
North America Hepatitis B Vaccine (Recombinant) market size was estimated at USD 280.59 million in 2023, at a CAGR of 2.66% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Hepatitis B Vaccine (Recombinant) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis B Vaccine (Recombinant) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis B Vaccine (Recombinant) market in any manner.
Global Hepatitis B Vaccine (Recombinant) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Merck
Sanofi Pasteur
Dynavax Technologies
LG Life Sciences
KM Biologics
Shenzhen Kangtai Biological Products
Serum Institute
Market Segmentation (by Type)
10mcg/0.5ml
10mcg/ml
Market Segmentation (by Application)
Newborn
Adult
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Hepatitis B Vaccine (Recombinant) Market
� Overview of the regional outlook of the Hepatitis B Vaccine (Recombinant) Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis B Vaccine (Recombinant) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hepatitis B Vaccine (Recombinant), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Vaccine (Recombinant)
1.2 Key Market Segments
1.2.1 Hepatitis B Vaccine (Recombinant) Segment by Type
1.2.2 Hepatitis B Vaccine (Recombinant) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hepatitis B Vaccine (Recombinant) Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hepatitis B Vaccine (Recombinant) Market Competitive Landscape
3.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2019-2025)
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2019-2025)
3.3 Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Hepatitis B Vaccine (Recombinant) Sales Sites, Area Served, Product Type
3.6 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
3.6.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Vaccine (Recombinant) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hepatitis B Vaccine (Recombinant) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2019-2025)
6.3 Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Type (2019-2025)
6.4 Global Hepatitis B Vaccine (Recombinant) Price by Type (2019-2025)
7 Hepatitis B Vaccine (Recombinant) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Vaccine (Recombinant) Market Sales by Application (2019-2025)
7.3 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2019-2025)
7.4 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2025)
8 Hepatitis B Vaccine (Recombinant) Market Consumption by Region
8.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region
8.1.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region
8.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis B Vaccine (Recombinant) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Hepatitis B Vaccine (Recombinant) Market Production by Region
9.1 Global Production of Hepatitis B Vaccine (Recombinant) by Region (2019-2025)
9.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2019-2025)
9.3 Global Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Hepatitis B Vaccine (Recombinant) Production
9.4.1 North America Hepatitis B Vaccine (Recombinant) Production Growth Rate (2019-2025)
9.4.2 North America Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Hepatitis B Vaccine (Recombinant) Production
9.5.1 Europe Hepatitis B Vaccine (Recombinant) Production Growth Rate (2019-2025)
9.5.2 Europe Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Hepatitis B Vaccine (Recombinant) Production (2019-2025)
9.6.1 Japan Hepatitis B Vaccine (Recombinant) Production Growth Rate (2019-2025)
9.6.2 Japan Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Hepatitis B Vaccine (Recombinant) Production (2019-2025)
9.7.1 China Hepatitis B Vaccine (Recombinant) Production Growth Rate (2019-2025)
9.7.2 China Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GSK
10.1.1 GSK Hepatitis B Vaccine (Recombinant) Basic Information
10.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Overview
10.1.3 GSK Hepatitis B Vaccine (Recombinant) Product Market Performance
10.1.4 GSK Business Overview
10.1.5 GSK Hepatitis B Vaccine (Recombinant) SWOT Analysis
10.1.6 GSK Recent Developments
10.2 Merck
10.2.1 Merck Hepatitis B Vaccine (Recombinant) Basic Information
10.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Overview
10.2.3 Merck Hepatitis B Vaccine (Recombinant) Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Hepatitis B Vaccine (Recombinant) SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Basic Information
10.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
10.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Market Performance
10.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) SWOT Analysis
10.3.5 Sanofi Pasteur Business Overview
10.3.6 Sanofi Pasteur Recent Developments
10.4 Dynavax Technologies
10.4.1 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Basic Information
10.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
10.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Market Performance
10.4.4 Dynavax Technologies Business Overview
10.4.5 Dynavax Technologies Recent Developments
10.5 LG Life Sciences
10.5.1 LG Life Sciences Hepatitis B Vaccine (Recombinant) Basic Information
10.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
10.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Market Performance
10.5.4 LG Life Sciences Business Overview
10.5.5 LG Life Sciences Recent Developments
10.6 KM Biologics
10.6.1 KM Biologics Hepatitis B Vaccine (Recombinant) Basic Information
10.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
10.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Product Market Performance
10.6.4 KM Biologics Business Overview
10.6.5 KM Biologics Recent Developments
10.7 Shenzhen Kangtai Biological Products
10.7.1 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Basic Information
10.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
10.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Market Performance
10.7.4 Shenzhen Kangtai Biological Products Business Overview
10.7.5 Shenzhen Kangtai Biological Products Recent Developments
10.8 Serum Institute
10.8.1 Serum Institute Hepatitis B Vaccine (Recombinant) Basic Information
10.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
10.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Product Market Performance
10.8.4 Serum Institute Business Overview
10.8.5 Serum Institute Recent Developments
11 Hepatitis B Vaccine (Recombinant) Market Forecast by Region
11.1 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast
11.2 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country
11.2.3 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region
11.2.4 South America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Hepatitis B Vaccine (Recombinant) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Type (2025-2032)
12.1.2 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Hepatitis B Vaccine (Recombinant) by Type (2025-2032)
12.2 Global Hepatitis B Vaccine (Recombinant) Market Forecast by Application (2025-2032)
12.2.1 Global Hepatitis B Vaccine (Recombinant) Sales (K MT) Forecast by Application
12.2.2 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis B Vaccine (Recombinant) Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Hepatitis B Vaccine (Recombinant) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2022)
Table 10. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Hepatitis B Vaccine (Recombinant) Sales Sites and Area Served
Table 12. Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
Table 13. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis B Vaccine (Recombinant)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Vaccine (Recombinant) Market Challenges
Table 22. Global Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 23. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 24. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2019-2025)
Table 25. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2019-2025)
Table 26. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2019-2025)
Table 27. Global Hepatitis B Vaccine (Recombinant) Market Size Share by Type (2019-2025)
Table 28. Global Hepatitis B Vaccine (Recombinant) Price (USD/MT) by Type (2019-2025)
Table 29. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application
Table 30. Global Hepatitis B Vaccine (Recombinant) Market Size by Application
Table 31. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2019-2025) & (K MT)
Table 32. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2019-2025)
Table 33. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2019-2025) & (M USD)
Table 34. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2019-2025)
Table 35. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2025)
Table 36. Global Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2025) & (K MT)
Table 37. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2019-2025)
Table 38. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2025) & (K MT)
Table 39. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2025) & (K MT)
Table 41. South America Hepatitis B Vaccine (Recombinant) Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Region (2019-2025) & (K MT)
Table 43. Global Hepatitis B Vaccine (Recombinant) Production (K MT) by Region (2019-2025)
Table 44. Global Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2019-2025)
Table 46. Global Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GSK Hepatitis B Vaccine (Recombinant) Basic Information
Table 52. GSK Hepatitis B Vaccine (Recombinant) Product Overview
Table 53. GSK Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GSK Business Overview
Table 55. GSK Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 56. GSK Recent Developments
Table 57. Merck Hepatitis B Vaccine (Recombinant) Basic Information
Table 58. Merck Hepatitis B Vaccine (Recombinant) Product Overview
Table 59. Merck Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Merck Business Overview
Table 61. Merck Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 62. Merck Recent Developments
Table 63. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Basic Information
Table 64. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
Table 65. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) SWOT Analysis
Table 67. Sanofi Pasteur Business Overview
Table 68. Sanofi Pasteur Recent Developments
Table 69. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Basic Information
Table 70. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
Table 71. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Dynavax Technologies Business Overview
Table 73. Dynavax Technologies Recent Developments
Table 74. LG Life Sciences Hepatitis B Vaccine (Recombinant) Basic Information
Table 75. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
Table 76. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. LG Life Sciences Business Overview
Table 78. LG Life Sciences Recent Developments
Table 79. KM Biologics Hepatitis B Vaccine (Recombinant) Basic Information
Table 80. KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
Table 81. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. KM Biologics Business Overview
Table 83. KM Biologics Recent Developments
Table 84. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Basic Information
Table 85. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
Table 86. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Shenzhen Kangtai Biological Products Business Overview
Table 88. Shenzhen Kangtai Biological Products Recent Developments
Table 89. Serum Institute Hepatitis B Vaccine (Recombinant) Basic Information
Table 90. Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
Table 91. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Serum Institute Business Overview
Table 93. Serum Institute Recent Developments
Table 94. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Hepatitis B Vaccine (Recombinant) Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD), 2019-2032
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) (2019-2032)
Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Vaccine (Recombinant) Market Size by Country (M USD)
Figure 11. Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis B Vaccine (Recombinant) Market Share by Type
Figure 18. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type (2019-2025)
Figure 19. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2023
Figure 20. Market Size Share of Hepatitis B Vaccine (Recombinant) by Type (2019-2025)
Figure 21. Market Size Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis B Vaccine (Recombinant) Market Share by Application
Figure 24. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2019-2025)
Figure 25. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2023
Figure 26. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2019-2025)
Figure 27. Global Hepatitis B Vaccine (Recombinant) Market Share by Application in 2023
Figure 28. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2019-2025)
Figure 30. North America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Hepatitis B Vaccine (Recombinant) Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Hepatitis B Vaccine (Recombinant) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2023
Figure 44. China Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (K MT)
Figure 50. South America Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Hepatitis B Vaccine (Recombinant) Production Market Share by Region (2019-2025)
Figure 62. North America Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2019-2025)
Figure 65. China Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Type (2025-2032)
Figure 70. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2025-2032)
Figure 71. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Application (2025-2032)
